Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Insulin Glulisine with Insulin Glargine in Type 1 Diabetes
NCT00545337Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2004
- Primary completion
- Jun 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glulisine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Sep 2004; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00545337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545337.